10x Genomics and PharosAI Launch Consortium to Build Multimodal Cancer Dataset

Reuters
02/04
<a href="https://laohu8.com/S/TXG">10x Genomics</a> and PharosAI Launch Consortium to Build Multimodal Cancer Dataset

10x Genomics Inc. has announced a partnership with PharosAI, a research consortium comprising King’s College London, Queen Mary University of London, Guy’s and St Thomas’ NHS Foundation Trust, and Barts Health NHS Trust. The collaboration will utilize 10x Genomics’ Xenium spatial platform to build one of the world’s largest and most comprehensive multimodal cancer datasets. Supported by £18.9 million from the UK Government’s Research Ventures Catalyst and additional industry and charity funding, the initiative aims to accelerate cancer diagnosis, enable precision therapies, and advance new treatment discoveries through AI-ready datasets and analytical tools.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 10x Genomics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA78184) on February 04, 2026, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10